Accession Number: | 0001209191-21-038655 |
Date: | 2021-06-03 |
Issuer: | NGM BIOPHARMACEUTICALS INC (NGM) |
Original Submission Date: |
CHEN JIN-LONG
333 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-06-03 | M | 69,444 | a | $1.44 | 989,449 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 1.44 | 2021-06-03 | deemed execution date | M | 69,444 (d) | 2022-03-01 | common stock 69,444 | $1.44 | 0 | direct |
ID | footnote |
---|---|
f1 | fully vested. |